News Releases

Johnson & Johnson to Host Investor Conference Call on the Phase 3 MARINER and COMMANDER HF Studies for XARELTO® NEW BRUNSWICK, N.J., Aug. 27, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:00 a.m. (Eastern Time) on Monday, August 27th, to review

NEW BRUNSWICK, N.J. , Aug. 20, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 10:00 a.m. (Eastern Time) on Thursday, September 13th, to review its Pharmaceutical Business.   Joaquin Duato, Vice Chairman of the Executive Committee; Jennifer Taubert,

  NEW BRUNSWICK, N.J. , Aug. 7, 2018 /PRNewswire/ --  Johnson & Johnson (NYSE: JNJ) will participate in the 2018 Wells Fargo 13 th Annual Healthcare Conference on Thursday, Sept. 6 th , at The Westin Copley Place  in Boston, MA.  Alex Gorsky, Chairman and Chief Executive Officer will represent the

NEW BRUNSWICK, N.J. , Aug. 7, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Barclays Global Consumer Staples Conference on Thursday, Sept. 6 th , at the InterContinental, Boston , MA.  Jorge Mesquita , Executive Vice President, Worldwide Chairman, Consumer will

SKILLMAN, N.J. , July 30, 2018 /PRNewswire/ -- Johnson & Johnson Consumer Inc. announced today that it has entered into a definitive agreement to acquire Zarbee's, Inc., a privately held company that is a leader in naturally-based healthcare products.  The acquisition will include the full line of

2018 Second-Quarter Sales of $20.8 Billion Increased 10.6% versus 2017
2018 Second-Quarter EPS was $1.45
2018 Adjusted Second-Quarter EPS of $2.10 increased 14.8%*
Accelerating Operational Sales Growth in the Second Quarter

NEW BRUNSWICK, N.J. , July 16, 2018 /PRNewswire/ --  Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the third quarter of 2018 of $0.90 per share on the company's common stock.  The dividend is payable on September 11, 2018 to shareholders